These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 31081082)

  • 41. miR-124-3p availability is antagonized by LncRNA-MALAT1 for Slug-induced tumor metastasis in hepatocellular carcinoma.
    Cui RJ; Fan JL; Lin YC; Pan YJ; Liu C; Wan JH; Wang W; Jiang ZY; Zheng XL; Tang JB; Yu XG
    Cancer Med; 2019 Oct; 8(14):6358-6369. PubMed ID: 31466138
    [TBL] [Abstract][Full Text] [Related]  

  • 42. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.
    He C; Liu Z; Jin L; Zhang F; Peng X; Xiao Y; Wang X; Lyu Q; Cai X
    Cell Physiol Biochem; 2018; 48(5):1928-1941. PubMed ID: 30092578
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long intergenic non-protein coding RNA 511 promotes the progression of osteosarcoma cells through sponging microRNA 618 to upregulate the expression of maelstrom.
    Guo W; Yu Q; Zhang M; Li F; Liu Y; Jiang W; Jiang H; Li H
    Aging (Albany NY); 2019 Aug; 11(15):5351-5367. PubMed ID: 31386627
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long noncoding RNA TPTE2P1 promotes the migration and invasion of hepatocellular carcinoma.
    Liu J; Wang Z; Yin Y; Li N; Ye NY; Bao B; Gu HC
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3733-3741. PubMed ID: 31114999
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression.
    Chang S; Chen B; Wang X; Wu K; Sun Y
    BMC Cancer; 2017 Apr; 17(1):248. PubMed ID: 28388883
    [TBL] [Abstract][Full Text] [Related]  

  • 46. lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214.
    Huang X; Gao Y; Qin J; Lu S
    Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G559-G565. PubMed ID: 29097358
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LINC00460 promotes hepatocellular carcinoma development through sponging miR-485-5p to up-regulate PAK1.
    Tu J; Zhao Z; Xu M; Chen M; Weng Q; Ji J
    Biomed Pharmacother; 2019 Oct; 118():109213. PubMed ID: 31376654
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long noncoding RNA LINC01139 promotes the progression of hepatocellular carcinoma by upregulating MYBL2 via competitively binding to miR-30 family.
    Li ZB; Chu HT; Jia M; Li L
    Biochem Biophys Res Commun; 2020 May; 525(3):581-588. PubMed ID: 32115147
    [TBL] [Abstract][Full Text] [Related]  

  • 49. LINC00511 promotes proliferation and invasion by sponging miR-515-5p in gastric cancer.
    Wang D; Liu K; Chen E
    Cell Mol Biol Lett; 2020; 25():4. PubMed ID: 32042282
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long non‑coding RNA AB019562 promotes cell proliferation and metastasis in human hepatocellular carcinoma.
    Wu F; Li J; Du X; Zhang W; Lei P; Zhang Q
    Mol Med Rep; 2017 Jul; 16(1):69-74. PubMed ID: 28534955
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long Non-Coding RNA PVT1/miR-150/ HIG2 Axis Regulates the Proliferation, Invasion and the Balance of Iron Metabolism of Hepatocellular Carcinoma.
    Xu Y; Luo X; He W; Chen G; Li Y; Li W; Wang X; Lai Y; Ye Y
    Cell Physiol Biochem; 2018; 49(4):1403-1419. PubMed ID: 30205391
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long non-coding RNAs HERH-1 and HERH-4 facilitate cyclin A2 expression and accelerate cell cycle progression in advanced hepatocellular carcinoma.
    Liu T; Shi Q; Yang L; Wang S; Song H; Wang Z; Xu X; Liu H; Zheng H; Shen Z
    BMC Cancer; 2021 Aug; 21(1):957. PubMed ID: 34445994
    [TBL] [Abstract][Full Text] [Related]  

  • 53. lncRNA A1BG-AS1 suppresses proliferation and invasion of hepatocellular carcinoma cells by targeting miR-216a-5p.
    Bai J; Yao B; Wang L; Sun L; Chen T; Liu R; Yin G; Xu Q; Yang W
    J Cell Biochem; 2019 Jun; 120(6):10310-10322. PubMed ID: 30556161
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overexpression of CASC19 contributes to tumor progression and predicts poor prognosis after radical resection in hepatocellular carcinoma.
    Hou Y; Tang Y; Ma C; Yu J; Jia Y
    Dig Liver Dis; 2023 Jun; 55(6):799-806. PubMed ID: 36805849
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
    Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LINC00657 knockdown suppresses hepatocellular carcinoma progression by sponging miR-424 to regulate PD-L1 expression.
    Cao X; Zhang G; Li T; Zhou C; Bai L; Zhao J; Tursun T
    Genes Genomics; 2020 Nov; 42(11):1361-1368. PubMed ID: 32996041
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Silencing of a novel lncRNA LOC105369748 suppresses the progression of hepatocellular carcinoma by sponging miR-5095 from MBD2.
    E C; Li C; Li H; Yang J
    J Cell Physiol; 2019 Aug; 234(10):18504-18512. PubMed ID: 30912130
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LncRNA DCST1-AS1 accelerates the proliferation, metastasis and autophagy of hepatocellular carcinoma cell by AKT/mTOR signaling pathways.
    Li J; Zhai DS; Huang Q; Chen HL; Zhang Z; Tan QF
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6091-6104. PubMed ID: 31364110
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SNHG7 Facilitates Hepatocellular Carcinoma Occurrence by Sequestering miR-9-5p to Upregulate CNNM1 Expression.
    Xie Y; Wang Y; Gong R; Lin J; Li X; Ma J; Huo L
    Cancer Biother Radiopharm; 2020 Dec; 35(10):731-740. PubMed ID: 32397799
    [No Abstract]   [Full Text] [Related]  

  • 60. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
    He Y; He X
    Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.